Literature DB >> 8351340

Asymptomatic and neurologically symptomatic HIV-seropositive subjects: results of long-term MR imaging and clinical follow-up.

M J Post1, J R Berger, R Duncan, R M Quencer, L Pall, D Winfield.   

Abstract

Cranial magnetic resonance (MR) images were prospectively obtained in 74 human immunodeficiency virus (HIV)-seropositive subjects, all of whom had undergone MR imaging 24-42 months earlier. The images were interpreted by neuroradiologists blinded to the subject's clinical status and were compared with the initial MR images and clinical findings. Ten subjects had mild neurologic symptoms, with mildly abnormal unchanged images in five (50%). Sixty-four subjects were neurologically asymptomatic, with mildly abnormal images in 13 (20%), most of which remained unchanged. chi 2 analysis revealed a significant difference (P = .042) between the asymptomatic and symptomatic groups with regard to the number of subjects with abnormal follow-up images. The number of abnormal images in the asymptomatic subjects was significantly less than that in the symptomatic subjects. During follow-up of 2-3 1/2 years, most asymptomatic subjects had persistently normal MR images. When abnormal, the imaging abnormalities were usually static and minor.

Entities:  

Mesh:

Year:  1993        PMID: 8351340     DOI: 10.1148/radiology.188.3.8351340

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  7 in total

1.  Independent effects of HIV, aging, and HAART on brain volumetric measures.

Authors:  Beau M Ances; Mario Ortega; Florin Vaida; Jodi Heaps; Robert Paul
Journal:  J Acquir Immune Defic Syndr       Date:  2012-04-15       Impact factor: 3.731

2.  Localised 1H-MR spectroscopy for metabolic characterisation of diffuse and focal brain lesions in patients infected with HIV.

Authors:  I L Simone; F Federico; C Tortorella; C F Andreula; G B Zimatore; P Giannini; G Angarano; V Lucivero; P Picciola; D Carrara; A Bellacosa; P Livrea
Journal:  J Neurol Neurosurg Psychiatry       Date:  1998-04       Impact factor: 10.154

3.  Progressive multifocal leukoencephalopathy in AIDS: are there any MR findings useful to patient management and predictive of patient survival? AIDS Clinical Trials Group, 243 Team.

Authors:  M J Post; C Yiannoutsos; D Simpson; J Booss; D B Clifford; B Cohen; J C McArthur; C D Hall
Journal:  AJNR Am J Neuroradiol       Date:  1999 Nov-Dec       Impact factor: 3.825

4.  1H MR spectroscopy of the brain in HIV-1-seropositive subjects: evidence for diffuse metabolic abnormalities.

Authors:  C D Marcus; S D Taylor-Robinson; J Sargentoni; J G Ainsworth; G Frize; P J Easterbrook; S Shaunak; D J Bryant
Journal:  Metab Brain Dis       Date:  1998-06       Impact factor: 3.584

Review 5.  Interactions of HIV and methamphetamine: cellular and molecular mechanisms of toxicity potentiation.

Authors:  J L Cadet; I N Krasnova
Journal:  Neurotox Res       Date:  2007-10       Impact factor: 3.911

6.  HIV Dementia.

Authors:  Avindra Nath; Joseph Berger
Journal:  Curr Treat Options Neurol       Date:  2004-03       Impact factor: 3.972

7.  Case control study: magnetic resonance spectroscopy of brain in HIV infected patients.

Authors:  Devender Bairwa; Virendra Kumar; Surabhi Vyas; Bimal Kumar Das; Achal Kumar Srivastava; Ravinder M Pandey; Surendra K Sharma; Naranamangalam R Jagannathan; Sanjeev Sinha
Journal:  BMC Neurol       Date:  2016-07-12       Impact factor: 2.474

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.